WO2007139199A1 - カテーテル用チューブ及びそれからなるカテーテル - Google Patents
カテーテル用チューブ及びそれからなるカテーテル Download PDFInfo
- Publication number
- WO2007139199A1 WO2007139199A1 PCT/JP2007/061137 JP2007061137W WO2007139199A1 WO 2007139199 A1 WO2007139199 A1 WO 2007139199A1 JP 2007061137 W JP2007061137 W JP 2007061137W WO 2007139199 A1 WO2007139199 A1 WO 2007139199A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tube
- catheter
- isobutylene
- copolymer
- block copolymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L53/02—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers of vinyl-aromatic monomers and conjugated dienes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/049—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F297/00—Macromolecular compounds obtained by successively polymerising different monomer systems using a catalyst of the ionic or coordination type without deactivating the intermediate polymer
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L53/02—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers of vinyl-aromatic monomers and conjugated dienes
- C08L53/025—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers of vinyl-aromatic monomers and conjugated dienes modified
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
- C08L75/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
- C08L75/04—Polyurethanes
- C08L75/08—Polyurethanes from polyethers
Definitions
- the present invention relates to a catheter tube that is percutaneously indwelled in the body and a force tenor using the tube.
- a central vein indwelling catheter is used when administering a high-calorie infusion or the like, and many of them are inserted into blood vessels by the through method.
- the insertion site is punctured with a needle, and the central venous catheter is advanced from that site to the superior vena cava called the central vein near the heart.
- the catheter base outside the body is inserted.
- a high-calorie infusion is administered from the end (Patent Documents 1 and 2).
- Patent Document 1 JP 2002-17860
- Patent Document 2 JP-A 63-71259
- polyurethane is made of polyurethane resin material, and because of the rigidity of the polyurethane resin material, if the catheter tip force S pulling force is pushed in at the time of insertion, the tip will be greatly curved, resulting in blood vessels There was a case of perforation when hitting a wall.
- silicone products may not be able to be inserted smoothly due to the softness and rubber elasticity of the silicone resin material, and may even stray in the blood vessels.
- the catheter was properly placed in the body, it was inadvertently placed by X-ray photography after the placement procedure. In some cases, it would take a lot of time to redo the process, and it would put a heavy burden on the patient.
- polyurethane-based tubes and silicone-based tubes have a problem that they cannot exert a therapeutic effect due to thrombus formation in and around the catheter.
- operability problems in handling (hereinafter referred to as operability) such as sticking of catheters to each other at the time of procedure or manufacture, or sticking to a packaging container when packaging the catheter.
- the present invention has been made to solve the above-described problems, and is a catheter tube excellent in penetration into the body, antithrombotic properties, and operability, and a catheter using the tube. Is intended to provide.
- an object of the present invention is to provide a catheter tube that can be adjusted to an arbitrary hardness by changing the mixing ratio of the materials used, and a catheter using the tube.
- the gist of the present invention is as follows:
- an isobutylene block copolymer composed of a polymer block (a) mainly composed of isobutylene and a polymer block (b) composed mainly of a different monomer from isobutylene.
- a catheter tube comprising a resin composition containing the coalesced (A) and the thermoplastic polyurethane resin (B);
- the catheter tube of the present invention can be adjusted to an arbitrary hardness by changing the blending ratio of the isobutylene block copolymer (A) and the thermoplastic polyurethane resin (B), and has various insertion properties.
- A isobutylene block copolymer
- B thermoplastic polyurethane resin
- FIG. 1 is a schematic view of a catheter produced using the tube obtained in the example.
- FIG. 4 is a surface electron micrograph (magnification: 100 times) of the tube (EG85A) obtained in Comparative Example 5. Explanation of symbols
- the isobutylene block copolymer (A) used in the present invention is a polymer block (a) mainly composed of isobutylene and a polymer block composed mainly of a different monomer component from isobutylene. (B).
- the polymer block refers to a chain block component constituting the block copolymer.
- the monomer different from isobutylene is not particularly limited as long as it is a monomer capable of cationic polymerization, but aliphatic olefins, aromatic burs, gens, butyl ethers, silanes, butyls. Examples thereof include monomers such as carbazole, ⁇ -pinene, and acenaphthylene. These can be used alone or in combination of two or more.
- Aliphatic olefin monomers include ethylene, propylene, 1-butene, 2_methyl_1-butene, 3_methyl_1-butene, pentene, hexene, cyclohexene, and 4-methylolene. 1_pentene, butylcyclohexane, otaten, norbornene and the like.
- Aromatic bule monomers include styrene, o_, m- or ⁇ methylstyrene, trimethylstyrene, ⁇ -methylstyrene, 2,6-dimethylstyrene, 2,4_dimethylstyrene, ⁇ —Methyl- ⁇ -methylstyrene, ⁇ -methyl-m-methylstyrene, ⁇ -methyl- ⁇ -methylstyrene, ⁇ -methyl- ⁇ -methylstyrene, ⁇ -methyl-m-methylstyrene, ⁇ -methyl- ⁇ -methylstyrene, 2, 4, 6 Trimethylstyrene, ⁇ -methyl Nore 2,6 Dimethylstyrene, ⁇ -Methyl-2,4 Dimethylstyrene, ⁇ -Methyl-2,6 Dimethylstyrene, ⁇ -Methyl-2,4 Dimethylstyrene, ⁇ —, m or
- Examples of the gen-based monomer include butadiene, isoprene, hexagen, cyclopentagen, cyclohexagen, dicyclopentagen, dibutenebenzene, ethylidene norbornene, and the like.
- butyl ether monomers include methyl butyl ether, ethyl vinyl ether, (n-, iso) propyl butyl ether, ( n- , sec-, tert-, iso) butyl vinyl ether, methyl propenyl ether, Ethyl propenyl ether etc. are mentioned.
- silane monomer examples include butyltrichlorosilane, butylmethyldichlorosilane, vinyldimethylchlorosilane, butyldimethylmethoxysilane, butyltrimethylsilane, divininoresichlorosilane, divinyldimethoxysilane, dibutyldimethylsilane, 1, Examples include 3-divinylol 1,1,1,3,3-tetramethyldisiloxane, tribumethylmethylsilane, and ⁇ -methacryloylsilane.
- the polymer block (b) having a monomer component different from isobutylene as a main component preferably has an aromatic bule monomer as a main component from the balance of physical properties and polymerization characteristics.
- the aromatic monomer it is preferable to use one or more monomers selected from the group consisting of styrene, hymethylstyrene, p-methylstyrene, and indene. From the viewpoint of cost, styrene, ⁇ —It is particularly preferable to use methylstyrene or a mixture thereof.
- the polymer block (b) containing a monomer component different from isopylene contains 60% by weight or more of an aromatic vinyl monomer. It is more preferable to contain 80% by weight or more.
- the polymer block (a) may or may not contain monomers other than isobutylene, but usually contains 60% by weight or more, preferably 80% by weight of isobutylene. Contain at least%.
- the monomer other than isoprene is not particularly limited as long as it is a monomer capable of cationic polymerization, and examples thereof include the above monomers.
- the isobutylene block copolymer (A) has a polymer block (a) mainly composed of isobutylene and a polymer block (b) mainly composed of a different monomer component from isobutylene.
- a block copolymer for example, a block copolymer, a diblock copolymer, a triblock copolymer, a multiblock copolymer, etc. having a linear, branched, or star structure. Either of these can be selected.
- a block copolymer a polymer block comprising an aromatic vinyl monomer as a main component, a polymer block comprising an isobutylene as a main component, and an aromatic bur monomer based on a balance between physical properties and polymerization characteristics.
- a triblock copolymer comprising a polymer block comprising as a main component, a polymer block comprising an aromatic vinyl monomer as a main component, a diblock copolymer comprising a polymer block comprising isobutylene as a main component, an aromatic And a star block copolymer having three or more arms each composed of a polymer block mainly composed of a group butyl monomer and a polymer block composed mainly of isobutylene. These can be used alone or in combination of two or more in order to obtain the desired physical properties and moldability.
- the ratio of the polymer block (a) to the polymer block (b) is not particularly limited, but the polymer block (b) may be 5 to 60% by weight from the physical property balance. It is particularly preferred to be 10-40% by weight.
- the ratio of the polymer block (b) is lower than the above range, the mechanical properties are not sufficiently expressed, whereas when it exceeds the above range, the gas permeability resistance (gas barrier derived from isobutylene) is exceeded. Property) is lowered, which is not preferable.
- the molecular weight of the isobutylene block copolymer (A) is not particularly limited, the number average molecular weight is preferably 30,000 to 500,000 from the viewpoint of fluidity, processability, physical properties, and the like. Ability to be between 50,000 and 200,000 S Especially preferred.
- the number average molecular weight of the isobutylene-based block copolymer is smaller than the above range, tackiness (tackiness) and softening agent bleed out tend to occur, and mechanical properties are not sufficiently expressed.
- the above range is exceeded, it is disadvantageous in terms of fluidity and workability.
- the monomer that is the main component of the polymer block (b) is an aromatic vinyl monomer, and the isobutylene block copolymer (A
- the weight ratio of the polymer block (b) is preferably 10 to 40% by weight.
- the number average of isobutylene block copolymer (A) The molecular weight force is S50000-200000, the monomer that is the main component of the polymer block (b) is styrene, and the weight ratio of the polymer block (b) in the isobutylene block copolymer (A) is It is preferably 10 to 40% by weight.
- the method for producing the isobutylene-based block copolymer (A) is not particularly limited.
- the body component and isobutylene can be obtained by polymerizing a monomer component mainly composed of a different monomer.
- X is a halogen atom, an alkoxy group having 1 to 6 carbon atoms or an acyloxy group
- a substituent selected from R 1 and R 2 is a hydrogen atom or a monovalent hydrocarbon group having 1 to 6 carbon atoms, respectively.
- R 2 may be the same or different.
- R 3 is a polyvalent aromatic hydrocarbon group or a polyvalent aliphatic hydrocarbon group, and n represents a natural number of:! -6.
- the compound represented by the above general formula (1) serves as an initiator, and is considered to generate a carbon cation in the presence of a Lewis acid or the like and serve as a starting point for cationic polymerization.
- Examples of the compound of the general formula (1) used in the present invention include (1 chloro 1-methylethyl) benzene [CHC (CH 2) Cl], 1,4-bis (1-chloro-1-1-methylethyl) benzene [1, 4— Cl (
- a Lewis acid catalyst may be allowed to coexist.
- Such Lewis acid may be any one that can be used for cationic polymerization.
- Metal halides such as CI, VC1, FeCl, ZnBr, A1C1, and AlBr; organometallic halides such as Et A1C1 and EtAlCl can be preferably used. Above all, ability as a catalyst
- TiCl, BC1, and SnCl are preferable.
- the amount of Lewis acid used is not particularly limited, but can be set in consideration of the polymerization characteristics or polymerization concentration of the monomer used. Usually, 0.1 to 100 molar equivalents can be used with respect to the compound represented by the general formula (1), preferably in the range of 1 to 50 molar equivalents.
- an electron donor component can be allowed to coexist if necessary.
- This electron donor component is considered to have an effect of stabilizing the growing carbon cation during the cationic polymerization, and a polymer whose molecular weight distribution is narrowed by the addition of the electron donor is controlled.
- the electron donor component that can be used is not particularly limited, and examples thereof include pyridines, amines, amides, sulfoxides, esters, and metal compounds having an oxygen atom bonded to a metal atom. it can.
- the polymerization of the isobutylene block copolymer (A) can generally be carried out in an organic solvent, and the organic solvent can be used without any particular limitation unless it essentially inhibits cationic polymerization. it can.
- halogenated hydrocarbons such as methyl chloride, dichloromethane, chloroform, chloroform, dichloroethane, n-propynole chloride, n-butyl chloride, chloroform, benzene, toluene, xylene, ethylbenzene, Alkylbenzenes such as propylbenzene and butylbenzene; linear aliphatic hydrocarbons such as ethane, propane, butane, pentane, hexane, heptane, octane, nonane and decane; 2-methylpropane, 2_methylbutane, 2 Branched aliphatic hydrocarbons such as 3,3_trimethyl
- solvents depend on the polymerization characteristics of the monomers constituting the block copolymer and In consideration of the balance of the solubility of the coalescence, it can be used alone or in combination of two or more.
- the amount of the solvent used is such that the concentration of the polymer is 1 to 50% by weight, preferably 5 to 35% by weight in consideration of the viscosity of the polymer solution obtained and ease of heat removal. It is determined.
- the respective components are mixed under cooling, for example, at a temperature of -100 ° C or higher and lower than 0 ° C.
- thermoplastic polyurethane resin (B) used in the present invention various thermoplastic urethane resins such as ester, ether and carbonate can be used.
- thermoplastic polyurethane resin (B) preferably has an ether bond.
- thermoplastic polyurethane resin (B) examples include a thermoplastic polyurethane resin comprising (i) an organic diisocyanate, (mouth) a chain extender, and (c) a polymer polyol.
- the thermoplastic polyurethane-based resin (B) may be manufactured by any method.
- the above (i) component and the (mouth) component and (c) component which are uniformly mixed in advance are mixed at high speed. This can be produced by casting it on a mold-treated bat and reacting it at a temperature of 200 ° C or lower, if necessary, or by adding (i) and (mouth) components.
- component (c) After making the isocyanate polymer prepolymer, add component (c), stir and mix at high speed, cast this onto a mold-treated vat, and react at a temperature of 200 ° C or lower as necessary. Conventionally known techniques can be used such as manufacturing.
- organic diisocyanate (i) conventionally known ones can be appropriately used.
- a dihydroxy compound having a molecular weight of less than 500 is used. I like it.
- polymer polyol (c) it is preferable to use a dihydroxy compound having an average molecular weight of 500 to 4000.
- examples of such include polyester diol, polyether diol, polycarbonate diol, and the like.
- Polyesterdiols include ethylene glycol, propylene glycol, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, neopentylglycol, 3-methinole-1,5-pentanediol , Cyclohexane dimethanol, or one or more other low molecular diol components and one or more low molecular dicarboxylic acids such as dartaric acid, suberic acid, sebacic acid, terephthalic acid, isophthalic acid And polylatatatone diol obtained by ring-opening polymerization of rataton, such as polypropiolataton diol, poly force prolataton diol, polyvalerolataton diol and the like.
- rataton such as polypropiolataton diol, poly force prolataton diol, polyvalerolataton diol and the like.
- polyether diol examples include polypropylene ether glycol, polytetramethylene ether glycol, polyhexamethylene ether glycol, and other copolymer polyether glycols.
- Polycarbonate diols include polyhexamethylene carbonate diol, diol obtained by ring-opening addition polymerization of ratatone to polyhexamethylene carbonate diol, polyhexamethylene carbonate diol and other polyester diols, polyether diols, polyether diols. Examples include co-condensates with ester diols.
- the hardness of the catheter tube can be adjusted by adjusting the ratio between the isobutylene block copolymer (A) and the thermoplastic polyurethane resin (B).
- the catheter tube of the present invention is prepared by mixing the isobutylene block copolymer (A) and the thermoplastic polyurethane resin (B) to prepare a resin composition for a tube, and this tube resin composition. It is obtained by processing an object as described later.
- the tube resin composition used in the present invention may be composed of only the isobutylene block copolymer (A) and the thermoplastic polyurethane resin (B), but may be mixed with other components.
- the total amount of component (A) and component (B) in the resin composition for tubes is preferably 50% by weight or more, more preferably 70% by weight or more, and more preferably 90% by weight or more. Further preferred.
- the resin composition for tubes may contain a polymer (C) as another component.
- the polymer (C) is an olefin polymer containing at least one functional group selected from the group consisting of an epoxy group, an amino group, a hydroxyl group, an acid anhydride group, a carboxynole group and a salt thereof, and a carboxylic acid ester. Or it consists of a styrene-type polymer.
- the term “polymer” as used herein includes copolymers, and there are no particular restrictions on the copolymerization mode, and any type of copolymer such as random copolymer, draft copolymer, or block copolymer may be used. There may be.
- olefin-based polymers and styrene-based polymers include ethylene propylene copolymer, ethylene-butene copolymer, ethylene-otaten copolymer, ethylene-hexene copolymer, and other ethylene'a.
- Olefin copolymers polyethylene, polypropylene, polystyrene, polybutene, ethylene-propylene-genogen copolymer, styrene-butadiene copolymer, styrene-butadiene-styrene block copolymer (SBS), styrene-isoprene-one Styrene block copolymer (SIS), polybutadiene, butadiene-acrylonitrile copolymer, polyisoprene, butene-isoprene copolymer, styrene-ethylenebutylene-styrene block copolymer (SEBS), styrene-ethylene pro Examples include pyrene-styrene block copolymer (SEPS).
- SEPS pyrene-styrene block copolymer
- polymer (C) having a functional group maleic anhydride, oxalic acid-free water may be added to an olefin-based polymer such as ethylene-a 1-year-old refin-based copolymer or a styrene-based polymer.
- styrene-ethylenebutylene-styrene copolymer maleic anhydride-modified SEBS having an acid anhydride group is preferred.
- SEBS maleic anhydride-modified SEBS
- the resin composition for a tube is based on the total amount of the isobutylene block copolymer (A), the thermoplastic polyurethane resin (B), and the polymer (C).
- the polymer (C) is preferably contained in an amount of 0.:! To 50% by weight, and more preferably in a range of! To 30% by weight.
- the compatibility of the isobutylene block copolymer ( ⁇ ) and the thermoplastic polyurethane resin ( ⁇ ) is not good, and the polymer (C) is added as a compatibilizing agent, it is less than 1% by weight. If the amount of the component is more than 30% by weight, the proportion of the ( ⁇ ) component in the composition decreases, and the flexibility of the catheter tube, gas permeability, and low resilience are reduced. It tends to be damaged.
- the polymer (C) may be added, for example, during the melt-kneading of the isobutylene block copolymer ( ⁇ ) and the thermoplastic polyurethane resin ( ⁇ ), and the isobutylene block copolymer in advance. It may be added to the coalescence ( ⁇ ) and the thermoplastic polyurethane resin ( ⁇ ). It is preferable to add them to the isobutylene block copolymer ( ⁇ ) and the thermoplastic polyurethane resin ( ⁇ ) in advance because the effect of improving the compatibility is manifested.
- a lubricant can be used as the component (D) in the tube resin composition, if necessary.
- lubricant fatty acid metal salt lubricants, fatty acid amide lubricants, fatty acid ester lubricants, fatty acid lubricants, aliphatic alcohol lubricants, partial esters of fatty acids and polyhydric alcohols, paraffin lubricants and the like are preferably used. Two or more types may be selected and used.
- Examples of the fatty acid metal salt lubricant include calcium stearate, magnesium stearate, aluminum stearate, zinc stearate, barium stearate, and metal montanate.
- Fatty acid amide-based lubricants include ethylene bis stearic acid amide, L force acid amide, oleic acid amide, stearic acid amide, behenic acid amide, ethylene bisoleic acid amide, ethylene bis erlic acid amide, Examples thereof include ethylene bislauric acid amide, m_xylylene bis stearic acid amide, and P-funylene bis stearic acid amide.
- Fatty acid ester lubricants include: methyl laurate, methyl myristate, methyl palmitate, methyl stearate, methyl oleate, methyl erucate, methyl behenate, butyl laurate, butyl stearate, myristic acid Isopropyl, isopropyl palmitate, octyl palmitate, octyl palm fatty acid, octyl stearate, special beef tallow fatty acid octyl, lauryl laurate, stearyl stearate, behenic acid behenic acid Nore, cetyl myristate, beef tallow hardened oil, castor hardened oil, montanic acid ester and the like.
- fatty acid-based lubricants include stearic acid, palmitic acid, oleic acid, linolenic acid, linolenic acid, and montanic acid.
- Examples of the aliphatic alcohol lubricant include stearyl alcohol, cetyl alcohol, myristyl alcohol, and lauryl alcohol.
- partial esters of fatty acids and polyhydric alcohols include stearic acid monodaricelide, stearic acid diglyceride, oleic acid monodarericide, and montanic acid partially saponified ester.
- paraffinic lubricant examples include paraffin wax, liquid paraffin, polyethylene wax, oxidized polyethylene wax, and polypropylene wax.
- fatty acid amide-based lubricants fatty acid ester-based lubricants, and paraffin-based lubricants are preferred because of the balance between moldability improving effect and cost.
- the lubricant (D) is preferably blended in an amount of 0.:! To 10 parts by weight with respect to 100 parts by weight of the total amount of the isobutylene block copolymer (A) and the thermoplastic polyurethane resin (B). When the amount is less than 1 part by weight, the slipperiness with the metal surface is insufficient, and there is a tendency for the workability and surface properties to decrease due to adhesion. There is a tendency for the ingredients to separate.
- a processing aid ( ⁇ ) may be added to the tube resin composition.
- the processing aid ( ⁇ ) acts for the purpose of improving the melt viscosity of the composition and improves the moldability during the molding process.
- Specific examples include an inorganic processability improver, an acrylic polymer processability improver, a polytetrafluoroethylene processability improver, and the like.
- polytetrafluoroethylene processability Specific examples of the improver include Metaprene (registered trademark) ⁇ 3000 manufactured by Mitsubishi Rayon Co., Ltd. and Lumiflon (registered trademark) manufactured by Asahi Glass Co., Ltd.
- the blending amount of the processing aid ( ⁇ ) is not particularly limited.
- the amount of the processing aid ( ⁇ ) is 0.1% relative to 100 parts by weight of the total amount of the isobutylene block copolymer ( ⁇ ) and the thermoplastic polyurethane resin ( ⁇ ). 1 to: It is preferable to add 10 parts by weight. 0. If the amount is less than 1 part by weight, the effect of improving the workability becomes insufficient. It tends to be good.
- Polyolefin resins can be blended into the tube resin composition as needed for the purpose of imparting molding fluidity.
- Polyolefin resins include a-olefin homopolymers, random copolymers, block copolymers and mixtures thereof, or random copolymers of olefin and other unsaturated monomers, block copolymers.
- a polymer, a graft copolymer, and an oxidized, halogenated or sulfonated one of these polymers can be used alone or in combination.
- polyethylene ethylene-propylene copolymer, ethylene-propylene-non-conjugated gen copolymer, ethylene-butene copolymer, ethylene-hexene copolymer, ethylene-otaten copolymer, ethylene-acetic acid Polyethylene such as bulle copolymer, ethylene-butyl alcohol copolymer, ethylene-ethyl acrylate copolymer, ethylene-acrylic acid copolymer, ethylene-methyl acrylate-maleic anhydride copolymer, chlorinated polyethylene Examples include resins, polypropylene, propylene-ethylene random copolymers, propylene-ethylene block copolymers, polypropylene resins such as chlorinated polypropylene, polybutene, polyisobutylene, polymethylpentene, cyclic olefin (co) polymers, and the like.
- polyethylene, polypropylene, or a mixture thereof can be preferably used from the viewpoint of the balance of physical properties of the cost and the thermoplastic resin.
- the blending amount of the polyolefin resin is 0 to 50% by weight, preferably 0 to 30% by weight based on the total amount of the isobutylene block copolymer (A), the thermoplastic polyurethane resin (B), and the polyolefin resin. %, More preferably 0 to 20% by weight. If it exceeds 50% by weight, the hardness tends to increase, which is not preferable.
- a softener may be used in the tube resin composition as needed.
- the kind of the softening agent is not particularly limited, but usually a liquid or liquid material is suitably used at room temperature. Both hydrophilic and hydrophobic softeners can be used.
- softeners include various rubber or resin softeners such as mineral oils, vegetable oils, and synthetics. As mineral oils, naphthenic, paraffinic and other process oils, etc.
- vegetable oils castor oil, cottonseed oil, linseed oil, rapeseed oil, soybean oil, palm oil, palm oil, peanut oil, wax
- Examples of the synthetic system include in-oil and olive oil, and polybutene, low-molecular weight polybutagen, and the like.
- phase with the isobutylene block copolymer (A) Paraffinic process oil or polybutene is preferably used from the viewpoint of the balance of physical properties of the soluble or thermoplastic polyurethane resin (B). These softeners can be used alone or in appropriate combination of two or more in order to obtain desired viscosity and physical properties.
- the amount of the softening agent is 0 to 50% by weight, preferably 0 to 30%, based on the total amount of the isobutylene block copolymer (A), the thermoplastic polyurethane resin (B), and the softening agent. % By weight, more preferably 0 to 20% by weight. If it exceeds 50% by weight, the softening agent tends to bleed out, which is not preferable.
- Suitable fillers can be blended in the tube resin composition from the viewpoint of improving physical properties or economic advantages.
- Suitable fillers include flaky inorganic fillers such as clay, diatomaceous earth, silica, talc, barium sulfate, calcium carbonate, magnesium carbonate, metal oxides, my strength, graphite, aluminum hydroxide, and various metals.
- flaky inorganic fillers such as clay, diatomaceous earth, silica, talc, barium sulfate, calcium carbonate, magnesium carbonate, metal oxides, my strength, graphite, aluminum hydroxide, and various metals.
- Examples include powder, wood chips, glass powder, ceramic powder, carbon black, granular or powdered solid fillers such as granular or powdered polymers, and other various natural or artificial short fibers and long fibers.
- weight reduction can be achieved by blending a hollow filler, for example, an inorganic hollow filler such as a glass balloon or a silica balloon, an organic hollow filler made of polyvinylidene fluoride or a polyvinylidene fluoride copolymer.
- a hollow filler for example, an inorganic hollow filler such as a glass balloon or a silica balloon, an organic hollow filler made of polyvinylidene fluoride or a polyvinylidene fluoride copolymer.
- various foaming agents can be mixed to improve various physical properties such as weight reduction and shock absorption, and it is also possible to mix gas mechanically when mixing each component. is there.
- the blending amount of the filler is 0 to 50% by weight, preferably 0 to 30%, based on the total amount of the isobutylene block copolymer (A), the thermoplastic polyurethane resin (B), and the filler. % By weight, more preferably 0 to 20% by weight. If it exceeds 50% by weight, the mechanical strength of the resulting tube for a catheter made of the tube resin composition tends to decrease, and the flexibility tends to be impaired.
- an antioxidant and / or an ultraviolet absorber can be blended in the tube resin composition as necessary.
- the blending amount is 0.01 to 10 parts by weight, preferably 0.01 to 5 parts by weight, with respect to 100 parts by weight of the thermoplastic resin.
- Other additives include flame retardants, antibacterial agents, light stabilizers, colorants, fluidity improvers, antiblocking agents, antistatic agents, bridges Bridging agents, crosslinking aids, etc. can be added, and these can be used alone or in combination of two or more.
- various thermoplastic resins, thermosetting resins, and other thermoplastic elastomers may be added to the tube resin composition. Etc. may be blended.
- a known method without particular limitation can be applied to the method for producing the resin composition for a tube having the above composition.
- each of the above components and optionally the additive component are melted using a heat kneader, for example, a single screw extruder, a twin screw extruder, a roll, a Banbury mixer, a Brabender, a kneader, a high shear mixer, etc. It can be produced by kneading.
- the kneading order of the components is not particularly limited, and can be determined according to the apparatus used, workability, or physical properties of the obtained tube resin composition.
- the catheter tube produced from the tube resin composition is a single-layer tube made of one kind of base material, a plurality of the tube resin compositions having different compositions are laminated, or A multilayer tube formed by laminating a plurality of layers composed of the above resin composition for tubes and other resin composition strength layers may be used.
- the catheter tube of the present invention is an infusion tube, a single-layer tube made of the above-mentioned tube resin composition, or a tube having a main layer or a central layer made of the above-mentioned tube resin composition. It may be.
- a coating layer (coating layer), an antistatic layer, and a layer made of another resin composition are formed on the upper layer and the lower layer of the above-described resin composition for tubes.
- gas barrier properties oxygen barrier properties, water vapor barrier properties, etc.
- light shielding properties anti-blocking properties, anti-slip properties, gamma ray resistance, heat resistance, polychlorinated bull-like feel
- the characteristics of the coating layer such as touch can be effectively exhibited, and the characteristics of the tube can be further improved.
- the tube surface (inner and outer surfaces) can be subjected to various processes such as embossing and various surface treatments such as acid treatment.
- the catheter tube of the present invention can be produced, for example, by extrusion molding.
- the tube resin composition obtained by the production method described above is put into an extruder. And after die extrusion, it can cool with water and a desired tube can be obtained.
- a highly transparent tube can be obtained.
- various catheter tubes can be obtained by processing these tubes.
- the catheter tube of the present invention is composed of a resin composition containing an isobutylene block copolymer (A) and a thermoplastic polyurethane resin (B), and has excellent physical properties.
- a tube in which the compressive stress between the thermoplastic polyurethane tube and the silicone tube is arbitrarily selected by blending can be produced. That is, it is preferable that the compression stress of the catheter tube of the present invention can be freely adjusted to be from 0.:! To 0.4 MPa at room temperature.
- the term “compressive stress” refers to that measured by the method described in Examples below.
- those having surface slipperiness (operability) superior to thermoplastic polyurethane tubes are preferred.
- the term “surface slipperiness” refers to that measured by the method described in Examples below.
- antithrombogenicity refers to that measured by the method described in Examples below.
- the catheter tube of the present invention has a compressive stress between a conventional thermoplastic polyurethane tube and a silicone tube, surface slipperiness and antithrombogenicity superior to those of a thermoplastic polyurethane tube. It is extremely useful as a tube having.
- the present invention also relates to a catheter using the catheter tube.
- a known method may be appropriately selected according to the type of catheter.
- the type of catheter is not particularly limited as long as the tube is inserted into the living body, a central vein placement catheter, an angiographic guidewire, a PTA balloon catheter, an angiographic catheter, a microcatheter, and thrombus removal.
- Catheter enteral feeding catheter, bile duct catheter, urinary catheter, bronchial tube, drainage tube, suction catheter, angiographic catheter, heart catheter, vasodilator catheter, thrombectomy catheter, epidural catheter, internal
- endoscopic catheters I can get lost.
- the catheter of the present invention has an excellent characteristic that it can be smoothly inserted into and removed from a living body.
- SIBS isobutylene block copolymer
- thermoplastic polyurethane resin (B) (hereinafter sometimes referred to as TPU), “Milactolan E385PNAT” (hereinafter abbreviated as E385) manufactured by Nippon Milactolan, which is an ether type aromatic cyclic polyurethane, or an ether type alicyclic ring “Tecoflex EG100A” and “Tecoflex EG85A” (hereinafter abbreviated as EG100A and EG85A, respectively) manufactured by Noveon Co., which are formula polyurethanes, were used.
- TPU thermoplastic polyurethane resin
- E385 a thermoplastic polyurethane resin manufactured by Nippon Milactolan, which is an ether type aromatic cyclic polyurethane, or an ether type alicyclic ring “Tecoflex EG100A” and “Tecoflex EG85A” (hereinafter abbreviated as EG100A and EG85A, respectively) manufactured by Noveon Co., which are formula
- 102T, E385, EG100A, and EG85A were mixed at the mixing ratio shown in Tables:! To 3, and the temperature was adjusted to a temperature near the hopper of 130 ° C, an intermediate portion of 190 ° C, and a tip portion of 180 ° C.
- the resin composition for the tube was subjected to SIBS / inner diameters of 0.75 mm and 1.55 mm, respectively, using a medical tube molding machine (single screw extruder) whose tip was adjusted to 200 ° C. TPU tube was molded.
- silicone tube of Comparative Example 1 (hereinafter abbreviated as “silicone”), a thermosetting medical tube extruder was used, and the inner and outer diameters were adjusted to 0.75 mm and 1.55 mm, respectively. Was molded.
- Each tube created above was cut into a length of 2 to 3 cm to obtain test samples.
- This test sample is sandwiched between the upper chuck of the tensile tester so that it protrudes 3 mm from the tip of the chuck, while the lower chuck of the tensile tester is removed and replaced with a horizontal base instead.
- a silicone sheet was placed on the surface. In this state, move the upper chuck downward at a speed of 5 mm / min, and measure the maximum load while the test sample protruding from the tip of the chuck contacts the silicone sheet and moves the chuck force Slmm. did. This maximum load was taken as a compressive stress and used as an index of insertability.
- Tables 1, 2 and 3 show tube types and test results, respectively.
- Comparative Example 5 was obtained in the same manner as Comparative Example 4 except that the mixing ratios shown in Tables 4 and 5 were used, and the inner and outer diameters of the tube were 0.9 Omm and 1.65 mm, respectively.
- Each of the above tubes was EOG sterilized and then cut into 30 cm to obtain test samples.
- the tube was filled with physiological saline in advance and plugged.
- the surface slipperiness was evaluated by the following method. A tube cut to a length of 30 cm was used, and the tactile sensation when sliding to the other end with the thumb and index finger was evaluated. The evaluation criteria are as follows. The test results are shown in Table 5.
- Comparative Example 5 EG85A
- the polymer block (a) containing isobutylene as a main component and Isobutylene is obtained by mixing an isobutylene block copolymer (A) composed of a polymer block (b) composed mainly of different monomer components with a thermoplastic polyurethane resin (B).
- A isobutylene block copolymer
- B thermoplastic polyurethane resin
- the reason why the tube according to the present invention as described above is excellent in antithrombogenicity is that the polymer block ( a ) having isobutylene as a main component and isobutylene are heavy components having different monomer components as main components. It can be said that the isobutylene block copolymer (A) composed of the combined block (b) has excellent characteristics.
- the polymer block (a) mainly composed of isobutylene is different from the isobutylene for the reason that the tube according to the present invention as described above is superior in surface slipperiness than the tube made of only polyurethane resin.
- the isobutylene block copolymer (A) composed of a polymer block (b) containing a monomer component as a main component has excellent characteristics.
- a tube manufactured using the tubes of the above-described embodiments has, for example, the configuration shown in FIG.
- a catheter 1 for central vein placement with a connector (hub) in the tube is illustrated.
- the catheter 1 includes a catheter body 2 having a tube and a connector 3.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/302,736 US7998124B2 (en) | 2006-05-31 | 2007-05-31 | Catheter tube and catheter comprising the tube |
JP2008517992A JP5338315B2 (ja) | 2006-05-31 | 2007-05-31 | カテーテル用チューブ及びそれからなるカテーテル |
EP07744525A EP2022512A4 (en) | 2006-05-31 | 2007-05-31 | CATHETER HOSE AND CATHETER WITH HOSE |
KR1020087027254A KR101326791B1 (ko) | 2006-05-31 | 2007-05-31 | 카테터용 튜브 및 그것으로 이루어지는 카테터 |
CN2007800203697A CN101460204B (zh) | 2006-05-31 | 2007-05-31 | 导管用管以及含该导管用管的导管 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006151706 | 2006-05-31 | ||
JP2006-151706 | 2006-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007139199A1 true WO2007139199A1 (ja) | 2007-12-06 |
Family
ID=38778716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/061137 WO2007139199A1 (ja) | 2006-05-31 | 2007-05-31 | カテーテル用チューブ及びそれからなるカテーテル |
Country Status (6)
Country | Link |
---|---|
US (1) | US7998124B2 (ja) |
EP (1) | EP2022512A4 (ja) |
JP (1) | JP5338315B2 (ja) |
KR (1) | KR101326791B1 (ja) |
CN (1) | CN101460204B (ja) |
WO (1) | WO2007139199A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008104766A (ja) * | 2006-10-27 | 2008-05-08 | Kaneka Corp | 医療用チューブ |
WO2009054524A1 (ja) * | 2007-10-27 | 2009-04-30 | Kaneka Corporation | バルーン用樹脂組成物及びそれからなるバルーン |
CN104066405A (zh) * | 2012-01-26 | 2014-09-24 | 株式会社钟化 | 泪道管 |
JP2020172559A (ja) * | 2019-04-08 | 2020-10-22 | コベストロ、ドイチュラント、アクチエンゲゼルシャフトCovestro Deutschland Ag | 熱可塑性ポリウレタン樹脂組成物及び成形体 |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2106414B1 (en) * | 2006-10-05 | 2014-08-20 | PolyOne Corporation | Thermoplastic elastomers of styrenic block copolymers and aliphatic thermoplastic polyurethanes |
WO2009158609A1 (en) | 2008-06-27 | 2009-12-30 | Cardiac Pacemakers, Inc. | Polyisobutylene urethane, urea and urethane/urea copolymers and medical devices containing the same |
JP5638003B2 (ja) | 2009-01-12 | 2014-12-10 | ユニバーシティ オブ マサチューセッツ ローウェル | ポリイソブチレン系ポリウレタン |
US8529934B2 (en) | 2009-08-21 | 2013-09-10 | Boston Scientific Scimed, Inc. | Crosslinkable polyisobutylene-based polymers and medical devices containing the same |
US8374704B2 (en) | 2009-09-02 | 2013-02-12 | Cardiac Pacemakers, Inc. | Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same |
US8644952B2 (en) * | 2009-09-02 | 2014-02-04 | Cardiac Pacemakers, Inc. | Medical devices including polyisobutylene based polymers and derivatives thereof |
US20120215153A1 (en) * | 2009-10-22 | 2012-08-23 | Kohei Fukaya | Tube device for insertion into lacrimal passage |
BR112013001758A2 (pt) * | 2010-08-05 | 2016-05-31 | Coloplast As | acondicionamento de cateter,e , conjunto de acondicionamento de cateter |
US20130131647A1 (en) * | 2010-08-05 | 2013-05-23 | Coloplast A/S | Flexible water vapour barrier multilayer tube for packaging purpose |
JP5739007B2 (ja) | 2010-12-20 | 2015-06-24 | カーディアック ペースメイカーズ, インコーポレイテッド | 導電性ポリマー導体を有するリード及びその製造方法 |
EP2922888B1 (en) | 2012-11-21 | 2021-08-18 | The University of Massachusetts | High strength polyisobutylene polyurethanes |
HUE063905T2 (hu) * | 2013-11-08 | 2024-02-28 | Hollister Inc | Síkosított oleofil katéterek |
US20150231306A1 (en) * | 2014-02-19 | 2015-08-20 | Lenn R. Hann | Coated medical device |
EP3592786B1 (en) | 2017-03-07 | 2023-05-10 | Cardiac Pacemakers, Inc. | Hydroboration/oxidation of allyl-terminated polyisobutylene |
CN110997746B (zh) | 2017-08-17 | 2021-12-28 | 心脏起搏器股份公司 | 用于增强的耐久性的光交联聚合物 |
WO2019143629A1 (en) | 2018-01-17 | 2019-07-25 | Cardiac Pacemakers, Inc. | End-capped polyisobutylene polyurethane |
CN109288565B (zh) * | 2018-09-21 | 2021-07-02 | 上海康德莱企业发展集团股份有限公司 | 一种一次性使用穿刺器 |
CN109288564B (zh) * | 2018-09-21 | 2021-06-01 | 上海康德莱企业发展集团股份有限公司 | 一种一次性使用腹腔镜穿刺器 |
CN109288563B (zh) * | 2018-09-21 | 2021-04-27 | 上海康德莱企业发展集团股份有限公司 | 一种腹腔镜手术穿刺器 |
CN109288562B (zh) * | 2018-09-21 | 2021-04-16 | 上海康德莱企业发展集团股份有限公司 | 一种腔镜手术用穿刺器 |
CN109288566B (zh) * | 2018-09-21 | 2021-06-01 | 上海康德莱企业发展集团股份有限公司 | 一种一次性低阻力穿刺器 |
KR102309875B1 (ko) | 2019-11-14 | 2021-10-12 | 주식회사 바스플렉스 | 카테터 내측 튜브용 수지 조성물 및 이를 이용한 내측 튜브 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6371259A (ja) | 1986-09-12 | 1988-03-31 | 日本ゼオン株式会社 | 留置用カテ−テル |
JPH0343424A (ja) * | 1989-06-14 | 1991-02-25 | Korea Advanced Inst Of Sci Technol | 血液適合性医療用材料 |
JPH05212104A (ja) * | 1992-02-07 | 1993-08-24 | Nippon Zeon Co Ltd | 熱可塑性医薬・医療用シ−ル性物品 |
JPH05269201A (ja) * | 1992-03-26 | 1993-10-19 | Nippon Zeon Co Ltd | 医薬・医療用容器 |
JPH05310868A (ja) * | 1992-05-11 | 1993-11-22 | Japan Synthetic Rubber Co Ltd | 医療材用組成物 |
JPH06172638A (ja) * | 1992-09-03 | 1994-06-21 | Becton Dickinson & Co | 熱可塑性ポリウレタンブレンド |
JPH08280790A (ja) * | 1995-04-17 | 1996-10-29 | Otsuka Pharmaceut Factory Inc | 医療用材料およびその製造方法 |
JP2000044788A (ja) * | 1998-07-27 | 2000-02-15 | Teijin Ltd | 抗血栓性に優れた高分子組成物及びそれからなる医療用材料 |
JP2000157627A (ja) * | 1998-11-26 | 2000-06-13 | Kuraray Co Ltd | 医療用具およびその成形材料 |
JP2002011092A (ja) * | 2000-04-27 | 2002-01-15 | Terumo Corp | カテーテルおよび医療用チューブ |
JP2002017860A (ja) | 2000-07-05 | 2002-01-22 | Nippon Sherwood Medical Industries Ltd | カテーテル |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4394462A (en) * | 1978-12-15 | 1983-07-19 | Hospal-Sodip, S.A. | Mixtures of polymers for medical use |
US4883699A (en) * | 1984-09-21 | 1989-11-28 | Menlo Care, Inc. | Polymeric article having high tensile energy to break when hydrated |
US5783633A (en) * | 1994-02-16 | 1998-07-21 | Schneider (Usa) Inc | Bicompatible polyisoprene-polyurethane interpenetrating polymer network compositions and medical devices made therefrom |
EP0823458B1 (en) * | 1995-04-28 | 2003-05-14 | Nof Corporation | Polymeric material, medical material and liquid polymer composition |
DE69629820T2 (de) * | 1995-08-03 | 2004-07-01 | Santerre, Paul J., Toronto | Fluoroligomere oberflächen modifizierungsmittel für polymere und die hieraus hergestellte gegenstände |
EP1149598A3 (en) * | 2000-04-27 | 2002-03-06 | Terumo Kabushiki Kaisha | Catheter and medical tube |
US7101956B2 (en) * | 2001-11-14 | 2006-09-05 | Medtronic, Inc. | Compounds containing quaternary carbons, medical devices, and methods |
US20050054774A1 (en) * | 2003-09-09 | 2005-03-10 | Scimed Life Systems, Inc. | Lubricious coating |
JP4490092B2 (ja) * | 2003-12-26 | 2010-06-23 | 株式会社カネカ | 熱可塑性樹脂組成物 |
EP1832792B1 (en) * | 2004-12-02 | 2014-06-18 | Kaneka Corporation | Resin composition for tubes and tube |
US20070005024A1 (en) * | 2005-06-10 | 2007-01-04 | Jan Weber | Medical devices having superhydrophobic surfaces, superhydrophilic surfaces, or both |
WO2009158609A1 (en) * | 2008-06-27 | 2009-12-30 | Cardiac Pacemakers, Inc. | Polyisobutylene urethane, urea and urethane/urea copolymers and medical devices containing the same |
-
2007
- 2007-05-31 CN CN2007800203697A patent/CN101460204B/zh active Active
- 2007-05-31 WO PCT/JP2007/061137 patent/WO2007139199A1/ja active Application Filing
- 2007-05-31 JP JP2008517992A patent/JP5338315B2/ja active Active
- 2007-05-31 KR KR1020087027254A patent/KR101326791B1/ko active IP Right Grant
- 2007-05-31 EP EP07744525A patent/EP2022512A4/en not_active Withdrawn
- 2007-05-31 US US12/302,736 patent/US7998124B2/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6371259A (ja) | 1986-09-12 | 1988-03-31 | 日本ゼオン株式会社 | 留置用カテ−テル |
JPH0343424A (ja) * | 1989-06-14 | 1991-02-25 | Korea Advanced Inst Of Sci Technol | 血液適合性医療用材料 |
JPH05212104A (ja) * | 1992-02-07 | 1993-08-24 | Nippon Zeon Co Ltd | 熱可塑性医薬・医療用シ−ル性物品 |
JPH05269201A (ja) * | 1992-03-26 | 1993-10-19 | Nippon Zeon Co Ltd | 医薬・医療用容器 |
JPH05310868A (ja) * | 1992-05-11 | 1993-11-22 | Japan Synthetic Rubber Co Ltd | 医療材用組成物 |
JPH06172638A (ja) * | 1992-09-03 | 1994-06-21 | Becton Dickinson & Co | 熱可塑性ポリウレタンブレンド |
JPH08280790A (ja) * | 1995-04-17 | 1996-10-29 | Otsuka Pharmaceut Factory Inc | 医療用材料およびその製造方法 |
JP2000044788A (ja) * | 1998-07-27 | 2000-02-15 | Teijin Ltd | 抗血栓性に優れた高分子組成物及びそれからなる医療用材料 |
JP2000157627A (ja) * | 1998-11-26 | 2000-06-13 | Kuraray Co Ltd | 医療用具およびその成形材料 |
JP2002011092A (ja) * | 2000-04-27 | 2002-01-15 | Terumo Corp | カテーテルおよび医療用チューブ |
JP2002017860A (ja) | 2000-07-05 | 2002-01-22 | Nippon Sherwood Medical Industries Ltd | カテーテル |
Non-Patent Citations (1)
Title |
---|
See also references of EP2022512A4 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008104766A (ja) * | 2006-10-27 | 2008-05-08 | Kaneka Corp | 医療用チューブ |
WO2009054524A1 (ja) * | 2007-10-27 | 2009-04-30 | Kaneka Corporation | バルーン用樹脂組成物及びそれからなるバルーン |
JPWO2009054524A1 (ja) * | 2007-10-27 | 2011-03-10 | 株式会社カネカ | バルーン用樹脂組成物及びそれからなるバルーン |
CN104066405A (zh) * | 2012-01-26 | 2014-09-24 | 株式会社钟化 | 泪道管 |
JP2020172559A (ja) * | 2019-04-08 | 2020-10-22 | コベストロ、ドイチュラント、アクチエンゲゼルシャフトCovestro Deutschland Ag | 熱可塑性ポリウレタン樹脂組成物及び成形体 |
JP7349255B2 (ja) | 2019-04-08 | 2023-09-22 | コベストロ、ドイチュラント、アクチエンゲゼルシャフト | 熱可塑性ポリウレタン樹脂組成物及び成形体 |
Also Published As
Publication number | Publication date |
---|---|
JP5338315B2 (ja) | 2013-11-13 |
KR20090017505A (ko) | 2009-02-18 |
EP2022512A1 (en) | 2009-02-11 |
US7998124B2 (en) | 2011-08-16 |
CN101460204B (zh) | 2012-10-03 |
KR101326791B1 (ko) | 2013-11-08 |
JPWO2007139199A1 (ja) | 2009-10-15 |
EP2022512A4 (en) | 2012-09-05 |
CN101460204A (zh) | 2009-06-17 |
US20090187162A1 (en) | 2009-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5338315B2 (ja) | カテーテル用チューブ及びそれからなるカテーテル | |
KR101224031B1 (ko) | 튜브용 수지 조성물 및 튜브 | |
JPWO2009054524A1 (ja) | バルーン用樹脂組成物及びそれからなるバルーン | |
JP2013536313A (ja) | 柔軟な材料およびそれから作製された物品 | |
JP6913735B2 (ja) | 樹脂組成物および生体モデル | |
JP2005344030A (ja) | 熱可塑性樹脂組成物 | |
JP4490092B2 (ja) | 熱可塑性樹脂組成物 | |
JP4819263B2 (ja) | 熱可塑性樹脂組成物 | |
CN104203296B (zh) | 医疗用多层管 | |
JP2008023071A (ja) | 医療用ドレーンチューブならびにその製造方法 | |
JP4000314B2 (ja) | 積層体および該積層体からなる医療用具 | |
JP2008023069A (ja) | 医療用ドレーンチューブ | |
JP2002011092A (ja) | カテーテルおよび医療用チューブ | |
JP2008023070A (ja) | 医療用ドレーンチューブならびにその製造方法 | |
JP2002088182A (ja) | 多孔性フィルム | |
JP2004097600A (ja) | サクションカテーテル | |
JP3407921B2 (ja) | 血管拡張用カテーテルシャフト | |
JP2008247972A (ja) | 熱可塑性樹脂組成物 | |
JPH025426B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780020369.7 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07744525 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087027254 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12302736 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008517992 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007744525 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |